about
Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino AcidsSite-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and GlycansExploring Structural Parameters for Pretargeting Radioligand Optimization.Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.Understanding the In Vivo Fate of Radioimmunoconjugates for PET and SPECT.Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability.Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.Dendrimer Scaffold for the Amplification of In Vivo Pretargeting Ligations.Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood ClearanceToward the Optimization of Click-Mediated Pretargeted RadioimmunotherapyDual Radionuclide Theranostic PretargetingIdentification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT
P50
Q28076701-B7C4331B-B15D-4266-AE6E-402BEC41E95CQ28078378-92A67365-067D-49FB-9B5B-0E249E71DC72Q48147491-565AEFAA-34B0-496A-BD60-B1C5D425B0B9Q48195034-A3784283-FA59-43EF-912C-C01D33DC4CB3Q52318963-6E0EF861-73B2-4AA7-B0AC-D7C6BACC296FQ52672070-C8FA4D73-58B9-4AC7-85D2-5A427A018269Q52675366-CAF6554C-7A6A-457A-AF24-C5A717DA142AQ64968923-AF344F9E-FADD-4D40-BE78-4C85C3A9FEBAQ89879563-88B33C87-D288-478D-A099-FAB2CAEB5CDBQ92626169-0D2078E9-CA95-49D6-95BA-3C186D481F1CQ93100651-FCF870E7-C61B-49A5-9638-D07708F20476Q96222104-21C4FBE8-9CB6-48E2-8E5A-F34C337667DE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Brian M Zeglis
@en
Brian M Zeglis
@nl
type
label
Brian M Zeglis
@en
Brian M Zeglis
@nl
prefLabel
Brian M Zeglis
@en
Brian M Zeglis
@nl
P31
P496
0000-0002-9091-744X